Search
Displaying 431–440 of 645 for “retinal diseases”
-
ProQR Announces Virtual Presentations at Scientific Conferences
ResourceProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA therapies for severe genetic rare diseases, today announced virtual presentations at the Ophthalmology Futures Retina Forum, European Society of Retina Specialists (Euretina) congress and the Annual Meeting of the American Academy of Optometry (AAOpt).
-
- Nov 1, 2025
- 9:00 a.m. (EDT)
- 100 Art Rooney Ave, Pittsburgh, PA 15212
VisionWalkVisionWalk is a fun, family-friendly 5K walk that supports the Foundation Fighting Blindness and our mission to find treatments and cures for blinding diseases. Join us for a day of community, celebration, and hope as we take steps toward a brighter future for those living with vision loss.
-
- Oct 18, 2025
- 9:00 a.m. (EDT)
- 15025 Bowl St, Charlotte , NC 28277
VisionWalkVisionWalk is a fun, family-friendly 5K walk that supports the Foundation Fighting Blindness and our mission to find treatments and cures for blinding diseases. Join us for a day of community, celebration, and hope as we take steps toward a brighter future for those living with vision loss.
-
- Oct 11, 2025
- 9:00 a.m. (EDT)
- 1255 Soldiers Fld Rd, Boston, MA 02135
VisionWalkVisionWalk is a fun, family-friendly 5K walk that supports the Foundation Fighting Blindness and our mission to find treatments and cures for blinding diseases. Join us for a day of community, celebration, and hope as we take steps toward a brighter future for those living with vision loss.
-
- Oct 4, 2025
- 9:00 a.m. (EDT)
- 599 Market St, Philadelphia, PA 19106
VisionWalkVisionWalk is a fun, family-friendly 5K walk that supports the Foundation Fighting Blindness and our mission to find treatments and cures for blinding diseases. Join us for a day of community, celebration, and hope as we take steps toward a brighter future for those living with vision loss.
-
Foundation Hosts Workshop on USH1B Research and Therapy Development
Research NewsEmerging dual-vector gene therapies to address current cargo-size limitations were highlighted during the meeting.
-
FFB-Funded Scientists Report on Nine Promising Translational Research Efforts
Research NewsThe Foundation Fighting Blindness has taken the translational challenge head on by investing more than $75 million in therapy-development projects with strong clinical-trial potential through its Translational Research Acceleration Program (TRAP), which includes Gund-Harrington Scholar Awards.
-
The Importance of Stem Cells (a guest post from Dr. David Gamm)
Research NewsDr. David Gamm on the potential of stem cell research to benefit patients with retinal degenerations.
-
Eye on the Cure Podcast | Episode 59: Dr. Robert MacLaren
Eye on the CureDr. Robert MacLaren, a world-renowned retinal surgeon, clinical trial investigator, and research lab leader at the University of Oxford, talks to host Ben Shaberman about the successes and challenges in retinal gene therapy development and clinical trials, as well as advances in robotics for improving retinal surgery outcomes.
-
First Patient Receives AON Therapy for LCA10 in ProQR’s Phase 2/3 Clinical Trial
Research NewsThe treatment, formerly known as QR-110, is designed for people with the retinal disease Leber congenital amaurosis 10
%20(1).png)
